not a bad effort but your basing off a 70 million 2020 revenue when they are going to pull close to 40 million for a quarter which if annualised looking forward with zero growth comes to 160 million. If you started looking forward from this quarter the valuation comes much higher so your way behind the 8 ball immediately and the guys running forward analysis are way ahead of you in terms of where the price can go. Also would look at running based off a PE for a Growth stock which is what zoono are. PE can range as high as 40-50
